SteriMax Announces Canadian Launch of Octreotide Injection

SteriMax is pleased to announce the launch of Octreotide Injection, designed to meet the practical needs of healthcare professionals while supporting the reliable supply of an essential therapy across Canada. Each unit of use includes a 2D barcode with variable data for improved traceability, and the product offers flexible storage—stable at room temperature for up to two weeks and refrigerated at 2°C–8°C for long‑term use.